Skip to main content

Universal Ibogaine Inc(IBO-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.005
Day High0.005
Open:0.005
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
PR Newswire
Canadian Investment Regulatory Organization Trade Resumption - IBO
AI-generated - The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Biotechnology Industry Stocks (IBO)
PR Newswire
Canadian Investment Regulatory Organization Trading Halt - IBO
AI-generated - The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Biotechnology Industry Stocks (IBO)
AI-generated - The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Biotechnology Industry Stocks (IBO)
AI-generated - The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Biotechnology Industry Stocks (IBO)
Baystreet
Stocks in play: Universal Ibogaine Inc.
AI-generated - The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Biotechnology Industry Stocks (IBO)
AI-generated - The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (IBO)
AI-generated - The Globe and Mail
Universal Ibogaine: Top 25 Performing Stocks Year-to-Date on TSX Venture Exchange (IBO)
AI-generated - The Globe and Mail
Universal Ibogaine: Top 25 Performing Stocks Year-to-Date on TSX Venture Exchange (IBO)
AI-generated - The Globe and Mail
Universal Ibogaine: Top 25 Performing Stocks Year-to-Date on TSX Venture Exchange (IBO)
AI-generated - The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (IBO)
AI-generated - The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (IBO)
AI-generated - The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Biotechnology Industry Stocks (IBO)
Baystreet
Stocks in play: Universal Ibogaine Inc.
The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Biotechnology Industry Stocks (IBO)
The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (IBO)
The Globe and Mail
Universal Ibogaine: Top 10 Undervalued Biotechnology Industry Stocks (IBO)
The Globe and Mail
Universal Ibogaine: Top 25 Undervalued TSX Venture Exchange Stocks (IBO)
Newswire.ca
Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference
ACCESS Newswire
The Power Play by The Market Herald Releases Interviews With Reyna Gold, Universal Ibogaine, NewRange Gold, Fabled Copper, and Fandom Sports Media
ACCESS Newswire
The Power Play by The Market Herald Releases New Interviews with Universal Ibogaine and Hank Payments on Their Latest News

Profile

Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.